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Aim: Evaluating respiratory symptoms in athletic individuals can be difficult and therefore robust 
clinical assessment tools are required (1). The Allergy Questionnaire for Athletes (AQUA) is validated 
to assess allergic +/- respiratory symptoms (2). The purpose of this study was therefore to determine 
the value of AQUA as a screening tool to confirm or refute exercise-induced bronchoconstriction 
(EIB) in athletes.  
Methods: One-hundred and forty-seven athletes (male: n = 100: female: n = 47) (age: 32 ± 9 years) 
completed AQUA and performed spirometry pre-and-post a eucapnic voluntary hyperpnoea 
challenge (EVH). A positive AQUA was determined as a score ≥5 (2). Sensitivity, specificity, positive 
predictive value (PPV) and negative predictive value (NPV) were calculated and evaluated against 
objective evidence of EIB: (EVH threshold [-10% ΔFEV1 at two consecutive time-points] and [-15% 
ΔFEV1 at one time-point]) (3). Diagnostic accuracy was calculated using receiver operating 
characteristics area under the curve (ROC-AUC). 
Results: All participants demonstrated normal baseline lung function (FEV1 % predicted >80%). The 
prevalence of EIB was 16% (-10% ΔFEV1) and 11% (-15% ΔFEV1) (mean ΔFEV1 = -7.4% ± 7.9). Eighty-
seven (59%) provided a positive AQUA score (range: 0-25). ROC-AUC for AQUA was 65% (-10% ΔFEV1) 
and 69% (-15% ΔFEV1). A negative AQUA score was highly predictive of negative EVH test outcome. 
Sensitivity, specificity, PPV and NPV are presented in Table 1. 
Conclusion: AQUA is a simple screening tool that provides value in ruling out EIB, and should be 
considered during clinical assessment (i.e. inform referral for objective testing) or as a ‘first-step’ as 
part of screening interventions. It is important to acknowledge that a positive AQUA score should not 
be used to confirm EIB, in the absence of indirect bronchoprovocation. The development and 
validation of an athlete specific questionnaire to confirm EIB remains an avenue for future research.   
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Table 1.  AQUA sensitivity, specificity, PPV and NPV for the detection of EIB.     
 
Population: n = 147 
 Prevalence (-10% ΔFEV1): 16% 
Prevalence (-15% ΔFEV1): 11% 
 EVH  
  -10% ΔFEV1  -15% ΔFEV1 
 + -  + - 
AQUA score 
+ 20 70 + 15 75 
- 3 54 - 1 56 
  AQUA score  
 -10% ΔFEV1  -15% ΔFEV1 
Sensitivity (%) 87  94 
Specificity (%) 44  43 
PPV (%) 22  17 
NPV (%) 95  98 
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